XIAP and non-small cell lung carcinoma: Combined with other drugs in treating NSCLC in vitro, TRAIL induced cell apoptosis by inhibiting BIRC4 expression and increasing cytotoxicity (Deok et al., 2018; Kim et al., 2019).